Iain Stuart - Net Worth and Insider Trading
Iain Stuart Net Worth
The estimated net worth of Iain Stuart is at least $189,937 dollars as of 2026-09-11. Iain Stuart is the Chief Scientific Officer of Foamix Pharmaceuticals Ltd and owns about 63,524 shares of Foamix Pharmaceuticals Ltd (FOMX) stock worth over $189,937. Details can be seen in Iain Stuart's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Iain Stuart has not made any transactions after 2019-07-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Iain Stuart
Iain Stuart Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Iain Stuart owns 2 companies in total, including VYNE Therapeutics Inc (VYNE) , and Foamix Pharmaceuticals Ltd (FOMX) .
Click here to see the complete history of Iain Stuart’s form 4 insider trades.
Insider Ownership Summary of Iain Stuart
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| VYNE | VYNE Therapeutics Inc | 2020-03-09 | Chief Scientific Officer |
| FOMX | Foamix Pharmaceuticals Ltd | 2020-03-09 | Chief Scientific Officer |
Iain Stuart Latest Holdings Summary
Iain Stuart currently owns a total of 1 stock. Iain Stuart owns 63,524 shares of Foamix Pharmaceuticals Ltd (FOMX) as of July 1, 2019, with a value of $189,937.
Latest Holdings of Iain Stuart
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FOMX | Foamix Pharmaceuticals Ltd | 2019-07-01 | 63,524 | 2.99 | 189,937 |
Holding Weightings of Iain Stuart
Iain Stuart Form 4 Trading Tracker
According to the SEC Form 4 filings, Iain Stuart has made a total of 0 transactions in Foamix Pharmaceuticals Ltd (FOMX) over the past 5 years. The most-recent trade in Foamix Pharmaceuticals Ltd is the sale of 951 shares on July 1, 2019, which brought Iain Stuart around $2,235.
Insider Trading History of Iain Stuart
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Iain Stuart Trading Performance
Iain Stuart Ownership Network
Ownership Network List of Iain Stuart
Ownership Network Relation of Iain Stuart
Iain Stuart Owned Company Details
What does VYNE Therapeutics Inc do?
Who are the key executives at VYNE Therapeutics Inc?
Iain Stuart is the Chief Scientific Officer of VYNE Therapeutics Inc. Other key executives at VYNE Therapeutics Inc include 10 percent owner Rtw Fund Group Gp, Llc , director & Chief Executive Officer Rebecca Frey , and Chief Development Officer Lori Payton .
VYNE Therapeutics Inc (VYNE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of VYNE Therapeutics Inc (VYNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of VYNE Therapeutics Inc (VYNE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
VYNE Therapeutics Inc (VYNE)'s detailed insider trading history can be found in Insider Trading Tracker table.
VYNE Therapeutics Inc Insider Transactions
Iain Stuart Mailing Address
Above is the net worth, insider trading, and ownership report for Iain Stuart. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Iain Stuart's mailing address is: Rehovot L3 76704.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
